Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia

被引:49
作者
De Luca, V [1 ]
Likhodi, O [1 ]
Van Tol, HHM [1 ]
Kennedy, JL [1 ]
Wong, AHC [1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON M5T 1R8, Canada
基金
加拿大健康研究院;
关键词
TPH2; bipolar disorder; schizophrenia; postmortem; expression; RT-PCR;
D O I
10.1007/s00213-005-0191-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The tryptophan hydroxylase isoform-2 gene (Tph2) is located on chromosome 12 and is expressed primarily in brain tissue. Although the tryptophan hydroxylase isoform-1 gene (Tph1) has been reported to have a genetic association with bipolar disorder and schizophrenia, the Tph1 isoform is expressed at much lower levels than Tph2 (150-fold less in the mouse brain). We hypothesized that bipolar disorder and schizophrenia are associated with abnormal levels of TPH2 mRNA in the brain. TPH2 and beta-actin mRNA levels in postmortem brain were quantified using real-time PCR. mRNA samples provided by the Stanley Foundation Array Collection were derived from the dorsolateral prefrontal cortex (Brodmann Area 46) of 35 bipolar, 35 schizophrenic, and 35 control subjects. There were significant differences in the mRNA levels among bipolar, schizophrenic, and normal subjects [F(2,102)=3.58; p=0.031]. A greater amount of TPH2 mRNA was found in the bipolar group in comparison with control subjects (Tukey's test: p=0.024). Further investigations of Tph2 are needed to clarify the potential role of this gene in the pathophysiology of bipolar disorder.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 23 条
[1]  
DELUCA V, 2005, INT J NEUROPSYCHOPH, P1
[2]   Tetrahydropterin-dependent amino acid hydroxylases [J].
Fitzpatrick, PF .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :355-381
[3]   The International HapMap Project [J].
Gibbs, RA ;
Belmont, JW ;
Hardenbol, P ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Ch'ang, LY ;
Huang, W ;
Liu, B ;
Shen, Y ;
Tam, PKH ;
Tsui, LC ;
Waye, MMY ;
Wong, JTF ;
Zeng, CQ ;
Zhang, QR ;
Chee, MS ;
Galver, LM ;
Kruglyak, S ;
Murray, SS ;
Oliphant, AR ;
Montpetit, A ;
Hudson, TJ ;
Chagnon, F ;
Ferretti, V ;
Leboeuf, M ;
Phillips, MS ;
Verner, A ;
Kwok, PY ;
Duan, SH ;
Lind, DL ;
Miller, RD ;
Rice, JP ;
Saccone, NL ;
Taillon-Miller, P ;
Xiao, M ;
Nakamura, Y ;
Sekine, A ;
Sorimachi, K ;
Tanaka, T ;
Tanaka, Y ;
Tsunoda, T ;
Yoshino, E ;
Bentley, DR ;
Deloukas, P ;
Hunt, S ;
Powell, D ;
Altshuler, D ;
Gabriel, SB ;
Qiu, RZ .
NATURE, 2003, 426 (6968) :789-796
[4]   A monoclonal antibody to tryptophan hydroxylase: applications and identification of the epitope [J].
Haycock, JW ;
Kumer, SC ;
Lewis, DA ;
Vrana, KE ;
Stockmeier, CA .
JOURNAL OF NEUROSCIENCE METHODS, 2002, 114 (02) :205-212
[5]   Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia [J].
López-Figueroa, AL ;
Norton, CS ;
López-Figueroa, MO ;
Armellini-Dodel, D ;
Burke, S ;
Akil, H ;
López, JF ;
Watson, SJ .
BIOLOGICAL PSYCHIATRY, 2004, 55 (03) :225-233
[6]   The spectrum of behaviors influenced by serotonin [J].
Lucki, I .
BIOLOGICAL PSYCHIATRY, 1998, 44 (03) :151-162
[7]   Pharmacogenetics of psychotropic drug response [J].
Malhotra, AK ;
Murphy, GM ;
Kennedy, JL .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (05) :780-796
[8]   A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical finding in major depression and suicide [J].
Mann, JJ ;
Huang, JY ;
Underwood, MD ;
Kassir, SA ;
Oppenheim, S ;
Kelly, TM ;
Dwork, AJ ;
Arango, V .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (08) :729-738
[9]   A tryptophan hydroxylase gene marker for suicidality and alcoholism [J].
Nielsen, DA ;
Virkkunen, M ;
Lappalainen, J ;
Eggert, M ;
Brown, GL ;
Long, JC ;
Goldman, D ;
Linnoila, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (07) :593-602
[10]   ORGANIZATION OF RAPHE-CORTICAL PROJECTIONS IN RAT - A QUANTITATIVE RETROGRADE STUDY [J].
OHEARN, E ;
MOLLIVER, ME .
BRAIN RESEARCH BULLETIN, 1984, 13 (06) :709-726